4//SEC Filing
Davis Chaim 4
Accession 0001491519-19-000002
CIK 0000896747other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 10:16 AM ET
Size
7.4 KB
Accession
0001491519-19-000002
Insider Transaction Report
Form 4
Davis Chaim
Director
Transactions
- Award
Common Shares
2019-06-20$0.07/sh+27,415$1,919→ 159,951 total - Other
Non-Statutory Stock Option
2019-06-20$0.07/sh+20,000$1,400→ 20,000 totalExercise: $0.07From: 2020-06-20Exp: 2029-06-20→ Common Shares (20,000 underlying)
Footnotes (4)
- [F1]27,415 common shares of restricted stock were issued to Davis as compensation for his attendance at a meeting of the Company's Board of Directors held on June 20, 2019. This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicated in the Company's Proxy Statement filed with the Commission on April 20, 2018).
- [F2]The volume weighted average price of the Company's common shares for the 10 days preceding the issuance was $0.0730 per share.
- [F3]The closing price of the Company's common shares on June 20, 2019 was $0.07.
- [F4]The stock option becomes 100% exercisable on June 20, 2020.
Documents
Issuer
AMERICAN BIO MEDICA CORP
CIK 0000896747
Entity typeother
Related Parties
1- filerCIK 0001491519
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 10:16 AM ET
- Size
- 7.4 KB